TRIM63 and cancer: A recent pan‐cancer TCGA‐based analysis comprehensively characterized the genomic and clinical profiles of IRF family genes across 33 tumour types, revealing that alterations such as SNPs, CNVs, and DNA methylation drive IRF dysregulation.